MetLife Investment Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $199K | Sell |
|
|||||
|
2025
Q2 | $218K | Buy |
|
|||||
|
2025
Q1 | $131K | Sell |
|
|||||
|
2024
Q4 | $321K | Buy |
|
|||||
|
2024
Q3 | $277K | Buy |
|
|||||
|
2024
Q2 | $136K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $127K | Buy |
|
|||||
|
2021
Q4 | $36.5K | Sell |
|
|||||
|
2021
Q3 | $197K | Hold |
|
|||||
|
2021
Q2 | $184K | Buy |
|
|||||
|
2021
Q1 | $27K | Sell |
|
|||||
|
2020
Q4 | $196K | Sell |
|
|||||
|
2020
Q3 | $266K | Hold |
|
|||||
|
2020
Q2 | $144K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $150K | Hold |
|
|||||
|
2019
Q2 | $400K | Buy |
|
|||||
|
2019
Q1 | $214K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $120K | Hold |
|
|||||
|
2017
Q4 | $121K | Buy |
|